R
Rodrigo Fabiano do Carmo Said
Researcher at Pan American Health Organization
Publications - 26
Citations - 879
Rodrigo Fabiano do Carmo Said is an academic researcher from Pan American Health Organization. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 6, co-authored 18 publications receiving 319 citations.
Papers
More filters
Journal ArticleDOI
Genomic and epidemiological monitoring of yellow fever virus transmission potential
Nuno R. Faria,Moritz U. G. Kraemer,Moritz U. G. Kraemer,Moritz U. G. Kraemer,Sarah C. Hill,Jaqueline Goes de Jesus,Renato S. Aguiar,Felipe Campos de Melo Iani,Joilson Xavier,Joshua Quick,L. du Plessis,Simon Dellicour,Julien Thézé,Rodrigo Dias de Oliveira Carvalho,Guy Baele,Chieh-Hsi Wu,Paola P. Silveira,Monica B. Arruda,Maira Alves Pereira,Gavin Pereira,José Lourenço,Uri Obolski,Leandro Abade,Tetyana I. Vasylyeva,Marta Giovanetti,Marta Giovanetti,D. Yi,Daniel J. Weiss,William Wint,Freya M Shearer,Sebastian Funk,Birgit Nikolay,Vagner Fonseca,Vagner Fonseca,Talita Émile Ribeiro Adelino,Marluce Aparecida Assunção Oliveira,Marcos Vieira Silva,Lívia Sacchetto,Poliana de Oliveira Figueiredo,Izabela Maurício de Rezende,Érica Munhoz de Mello,Rodrigo Fabiano do Carmo Said,Deise Aparecida dos Santos,Marcela Lencine Ferraz,Mariana Gontijo de Brito,Ludmila Ferraz de Santana,Mariane Talon de Menezes,Rodrigo Brindeiro,Amilcar Tanuri,Fabiana Cristina Pereira dos Santos,Mariana Sequetin Cunha,Juliana Silva Nogueira,Iray Maria Rocco,A. C. da Costa,Shirley Vasconcelos Komninakis,Vasco Azevedo,Alexandre Otavio Chieppe,Eliane Saraiva Machado de Araújo,Marcos Cesar Lima de Mendonça,Carolina Cardoso dos Santos,Cintia Damasceno dos Santos Rodrigues,Maria Angelica Mares Guia,Rita Maria Ribeiro Nogueira,Patrícia Carvalho de Sequeira,Ricardo Gadelha de Abreu,Marcio Henrique de Oliveira Garcia,André Luis de Abreu,Osnei Okumoto,Erna Geessien Kroon,Carlos Frederico Campelo de Albuquerque,Kuiama Lewandowski,Steven T. Pullan,Miles W. Carroll,T. de Oliveira,T. de Oliveira,T. de Oliveira,Ester Cerdeira Sabino,Renato Pereira de Souza,Marc A. Suchard,Philippe Lemey,Giliane de Souza Trindade,Betânia Paiva Drumond,Ana Maria Bispo de Filippis,Nicholas J. Loman,Simon Cauchemez,Luiz Carlos Junior Alcantara,Luiz Carlos Junior Alcantara,Oliver G. Pybus +87 more
TL;DR: It is shown that the age and sex distribution of human cases is characteristic of sylvatic transmission, which establishes a framework for monitoring YFV transmission in real time that will contribute to a global strategy to eliminate future YFFV epidemics.
Journal ArticleDOI
Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
Otavio T. Ranzani,Matthew D. Hitchings,Murilo Dorion,Tatiana Lang D'Agostini,Regiane Cardoso de Paula,Olivia Ferreira Pereira de Paula,Edlaine Faria de Moura Villela,Mario Sergio Scaramuzzini Torres,Silvano Barbosa de Oliveira,Silvano Barbosa de Oliveira,Wade L. Schulz,Maria Almiron,Rodrigo Fabiano do Carmo Said,Roberto Dias de Oliveira,Patricia Vieira da Silva,Wildo Navegantes de Araújo,Wildo Navegantes de Araújo,Jean Carlo Gorinchteyn,Jason R. Andrews,Derek A. T. Cummings,Albert I. Ko,Albert I. Ko,Julio Croda,Julio Croda,Julio Croda +24 more
TL;DR: In this paper, the authors estimate the effectiveness of the inactivated whole virus vaccine, CoronaVac, against symptomatic covid-19 in the elderly population of Sao Paulo state, Brazil during widespread circulation of the gamma variant.
Journal ArticleDOI
Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study.
Matthew D. Hitchings,Otavio T. Ranzani,Mario Sergio Scaramuzzini Torres,Silvano Barbosa de Oliveira,Silvano Barbosa de Oliveira,Maria Almiron,Rodrigo Fabiano do Carmo Said,Ryan Borg,Wade L. Schulz,Roberto Dias de Oliveira,Patricia Vieira da Silva,Daniel Castro,Vanderson de Souza Sampaio,Bernardino Cláudio de Albuquerque,Tatyana Costa Amorim Ramos,Shadia Hussami Hauache Fraxe,Cristiano Fernandes da Costa,Felipe Gomes Naveca,André Siqueira,Wildo Navegantes de Araújo,Wildo Navegantes de Araújo,Jason R. Andrews,Derek A. T. Cummings,Albert I. Ko,Albert I. Ko,Julio Croda,Julio Croda,Julio Croda +27 more
TL;DR: In this paper, the authors performed a matched test-negative case-control study to estimate the effectiveness of an inactivated vaccine, CoronaVac, in healthcare workers (HCWs) in Manaus, where the Gamma variant accounted for 86% of genotyped SARS-CoV-2 samples at the peak of its epidemic.
Posted ContentDOI
Effectiveness of an Inactivated Covid-19 Vaccine with Homologous and Heterologous Boosters against the Omicron (B.1.1.529) Variant
Otavio T. Ranzani,M Hitchings,Robson L. Melo,Giovanny Vinícius Araújo de França,Cloé D. Fernandes,Magnus Lind,M. S. S. Torres,Daniel Henrique Tsuha,L. David,Rodrigo Fabiano do Carmo Said,Maria Almiron,Roberto Dias de Oliveira,Derek A. T. Cummings,Nesreen Mohamad Zain El Dean,Jocelyn Rae Andrews,A. Ko,Julio Croda +16 more
TL;DR: A homologous CoronaVac booster dose provided limited additional protection, while a BNT162b2 booster dose afforded sustained protection against severe disease for at least three months.
Journal ArticleDOI
Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo.
Matthew D. Hitchings,Otavio T. Ranzani,Murilo Dorion,Tatiana Lang D'Agostini,Regiane Cardoso de Paula,Olivia Ferreira Pereira de Paula,Edlaine Faria de Moura Villela,Mario Sergio Scaramuzzini Torres,Silvano Barbosa de Oliveira,Silvano Barbosa de Oliveira,Wade L. Schulz,Maria Almiron,Rodrigo Fabiano do Carmo Said,Roberto Dias de Oliveira,Patricia Vieira da Silva,Wildo Navegantes de Araújo,Wildo Navegantes de Araújo,Jean Carlo Gorinchteyn,Jason R. Andrews,Derek A. T. Cummings,Albert I. Ko,Albert I. Ko,Julio Croda,Julio Croda,Julio Croda +24 more
TL;DR: In this article, the effectiveness of the two-dose Covid-19 vaccine schedule was evaluated in elderly populations in countries with high prevalence of the Gamma variant of SARS-CoV-2.